ATE26797T1 - Entzuendungshemmende zusammensetzung. - Google Patents
Entzuendungshemmende zusammensetzung.Info
- Publication number
- ATE26797T1 ATE26797T1 AT83100597T AT83100597T ATE26797T1 AT E26797 T1 ATE26797 T1 AT E26797T1 AT 83100597 T AT83100597 T AT 83100597T AT 83100597 T AT83100597 T AT 83100597T AT E26797 T1 ATE26797 T1 AT E26797T1
- Authority
- AT
- Austria
- Prior art keywords
- carbon atoms
- alkyl
- phenylene
- hydrogen
- carboxy
- Prior art date
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 7
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 abstract 1
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 abstract 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000002723 alicyclic group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- -1 carboxy ester Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052805 deuterium Inorganic materials 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229940124550 renal vasodilator Drugs 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP83100597A EP0114172B1 (de) | 1983-01-24 | 1983-01-24 | Entzündungshemmende Zusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE26797T1 true ATE26797T1 (de) | 1987-05-15 |
Family
ID=8190254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT83100597T ATE26797T1 (de) | 1983-01-24 | 1983-01-24 | Entzuendungshemmende zusammensetzung. |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0114172B1 (de) |
| AT (1) | ATE26797T1 (de) |
| DE (1) | DE3371169D1 (de) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4130566A (en) * | 1977-10-27 | 1978-12-19 | Sumitomo Chemical Company, Limited | Process for producing 5-carboxy-2-acetylthiophene |
| US4379792A (en) * | 1980-10-30 | 1983-04-12 | Merck & Co., Inc. | Anti-inflammatory composition |
-
1983
- 1983-01-24 AT AT83100597T patent/ATE26797T1/de active
- 1983-01-24 DE DE8383100597T patent/DE3371169D1/de not_active Expired
- 1983-01-24 EP EP83100597A patent/EP0114172B1/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0114172B1 (de) | 1987-04-29 |
| EP0114172A1 (de) | 1984-08-01 |
| DE3371169D1 (en) | 1987-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8704461A1 (es) | Procedimiento para la produccion de derivados diarilicos de compuestos antiinflamatorios antialergicos. | |
| ES8205771A1 (es) | Un procedimiento para la obtencion de un derivado acilado sustituido de acido octahidro-1h-indol-2-carboxilico | |
| MX9200109A (es) | Derivados de acridina, procedimiento para su prepaderivados de acridina, procedimiento para su preparacion y composicion farmaceutica que los contieneracion y composicion farmaceutica que los contiene. . | |
| ES2021266B3 (es) | Nuevos derivados de quinazolina, procedimiento para su produccion y composiciones farmaceuticas que los contienen. | |
| PT941082E (pt) | Nova utilizacao para derivados de 1,3-propanodiol | |
| AU557953B2 (en) | Benzene butanoic acid derivatives leukotriene antagonists | |
| BG97221A (bg) | Ортозаместени бифениламидини и бифенилизанидини и съдържащите ги антидиабетични или хипогликемични средства | |
| ES526065A0 (es) | Un procedimiento para la preparacion de nuevos derivados propil fenoxibencenicos. | |
| ATE26797T1 (de) | Entzuendungshemmende zusammensetzung. | |
| SE8303913D0 (sv) | Heterocykliska foreningar | |
| ATE38675T1 (de) | Phosphatesterderivate und ihre verwendung als anti-krebsmittel. | |
| DK274086A (da) | Substituerede phenyleddikesyreamidforbindelser og farmaceutisk acceptable salte heraf samt farmaceutisk komposition med antiinflammatorisk og analgetisk virkning indeholdende disse | |
| IL71639A0 (en) | Imidazoline derivatives,processes for their preparation,pharmaceutical compositions containing them and their use as histamine h2-antagonists | |
| NO891608D0 (no) | Heterotetracykliske laktamderivater. | |
| IT1204462B (it) | Derivati eterociclici | |
| PT87790A (pt) | A process for the preparation of ergoline derivatives and of pharmaceutical compositions containing the same | |
| DE69523819D1 (de) | Quinolin-Derivate und diese enthaltende pharmazeutische Zusammensetzungen |